Rheumatoid arthritis (RA) is a prototype inflammatory disease characterized by leukocyte infiltration, which is in large part mediated by chemokines and cellular adhesion molecules. Angiogenesis, or new blood vessel growth, is integral to the development of the inflamed RA synovial tissue (ST) pannus. Without angiogenesis, leukocyte infiltration could not occur. A novel cytokine, interleukin (IL)-I8 has recently been identified. This cytokine stimulates T helper 1 (Thl) cytokine production by T cells. The functional role of this cytokine in RA is still unclear. In this proposal we hypothesize that IL-18 contributes to RA joint inflammation and angiogenesls. We plan to determine the mechanism by which IL-18 serves as an inducer of chemokine production in RA ST fibroblasts and whether this chemokine production occurs via G proteins, src family kinases, mitogen activated kinases, or PI3 kinases. Besides chemokines, cellular adhesion molecules are needed for leukocyte ingress into inflamed STs. We will examine whether IL-18 induces leukocyte-endothelial adhesion molecule expression and the mechanism of this expression. Finally, leukocyte ingress would not take place without angiogenesis. We will ascertain the mechanism by which IL-18 mediates angiogenesis in RA in terms of the endothelial signaling pathways, which are activated. Finally, we will study IL-18 gene-deficient mice to determine if they have impaired angiogenesis. We will employ these gene deficient animals bred on an arthritis-susceptible strain to examine whether arthritis associated angiogenesis in the joints is decreased. Several years ago cytokine modulation as a therapy for RA was simply a hope. Currently, cytokine modulation aimed at ablating tumor necrosis factor-alpha is one of the best treatments available for RA and IL-1 targeting is beginning to be used therapeutically. IL-18, by virtue of its ability to induce chemokine release, adhesion molecule expression, and angiogenesis, appears to be a very critical cytokine to target. Our proposal should answer some key questions, which may determine the ability of IL-18 to be a therapeutic target in RA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR048267-05
Application #
7279466
Study Section
Special Emphasis Panel (ZRG1-GMA-1 (01))
Program Officer
Mancini, Marie
Project Start
2003-09-01
Project End
2010-08-31
Budget Start
2007-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2007
Total Cost
$246,710
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Amin, Mohammad A; Campbell, Phillip L; Ruth, Jeffrey H et al. (2015) A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis. Ann Rheum Dis 74:1459-66
Tsou, Pei-Suen; Ruth, Jeffrey H; Campbell, Phillip L et al. (2013) A novel role for inducible Fut2 in angiogenesis. Angiogenesis 16:195-205
Isozaki, Takeo; Arbab, Ali S; Haas, Christian S et al. (2013) Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis. Arthritis Rheum 65:1736-46
Tsou, Pei-Suen; Talia, Nadine N; Pinney, Adam J et al. (2012) Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis Rheum 64:1978-89
Rabquer, Bradley J; Hou, Yong; Ruth, Jeffrey H et al. (2012) H-2g, a glucose analog of blood group H antigen, mediates monocyte recruitment in vitro and in vivo via IL-8/CXCL8. Open Access Rheumatol 4:93-98
Bank, Lisa M; Bianchi, Lynne M; Ebisu, Fumi et al. (2012) Macrophage migration inhibitory factor acts as a neurotrophin in the developing inner ear. Development 139:4666-74
Rabquer, Bradley J; Tsou, Pei-Suen; Hou, Yong et al. (2011) Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther 13:R18
Prossin, Alan R; Koch, Alisa E; Campbell, Phillip L et al. (2011) Association of plasma interleukin-18 levels with emotion regulation and ?-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry 69:808-12
Marotte, Hubert; Tsou, Pei-Suen; Rabquer, Bradley J et al. (2011) Blocking of interferon regulatory factor 1 reduces tumor necrosis factor ?-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1 Arthritis Rheum 63:3253-62
Marotte, Hubert; Ruth, Jeffrey H; Campbell, Phillip L et al. (2010) Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology (Oxford) 49:467-79

Showing the most recent 10 out of 59 publications